Patients afflicted by Gorlin syndrome present with loss of PTCH1 heterozygosity, increasing the likelihood of developing a distinct set of solid tumors: BCC, medulloblastoma, and rhabdomyosarcoma [177]. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.